Medication info
Glimaril M Tablet 2/500 mg

Glimaril M Tablet 2/500 mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Korea United Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablet
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201109149 · Approved 2011.10.25 · Insurance code 644308240

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine should be administered 1∼2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and based on blood glucose monitoring results, it was gradually increased up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride monotherapy, there is generally little additional effect with doses exceeding 4mg per day, although better metabolic control was observed in some patients when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer based on the dosage and administration schedule of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next administration.

Ingredients

Manufacturer
Korea United Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medicine is used to assist dietary therapy and exercise therapy for the improvement of blood sugar control in patients with type 2 diabetes. In particular, it helps enhance blood sugar control effects by combining Glimipiride and Metformin. Therefore, it is recommended as a suitable treatment option for patients who have difficulty managing blood sugar.

How to take

Adult dose

This medicine should be administered 1∼2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and based on blood glucose monitoring results, it was gradually increased up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride monotherapy, there is generally little additional effect with doses exceeding 4mg per day, although better metabolic control was observed in some patients when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer based on the dosage and administration schedule of the glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next administration.

Precautions

This medicine may cause severe lactic acidosis or hypoglycemia; therefore, treatment should be discontinued and a doctor should be consulted if renal function declines sharply. It is advisable to temporarily stop taking this medicine if symptoms of dehydration, severe diarrhea, vomiting, or fever occur, and these symptoms should be reported to a healthcare professional. Caution is required when taking other medications, especially antihypertensives, diuretics, or non-steroidal anti-inflammatory drugs that may affect kidney function. Due to the risk of cardiovascular disease, cardiovascular health should be periodically checked during treatment with this medicine. Insulin-dependent diabetes patients or patients with acute metabolic acidosis, severe liver or kidney dysfunction, pregnant and nursing patients should not take this medicine. Particularly, patients with a kidney function less than 45 mL/min/1.73 m2 should not use this medicine, and administration should be immediately ceased if renal impairment is suspected. Patients at high risk for hypoglycemia (elderly, malnourished, irregular meals, intense exercise, alcohol consumers, etc.) require particularly careful monitoring during initial treatment and dosage adjustments. Gastrointestinal symptoms (diarrhea, nausea, vomiting, abdominal pain, etc.) may occur during use, but most are temporary and can be reduced by taking it with meals. If allergic reactions or severe skin rashes, dyspnea, etc. occur, notify a physician immediately, and regular blood tests are necessary as blood abnormalities (thrombocytopenia, anemia, etc.) may occur. Vitamin B12 deficiency may occur; therefore, check serum vitamin B12 levels during long-term treatment and consider supplementation if necessary. This medication may interact with other drugs, so inform healthcare professionals of any other medications being taken, especially when combined with drugs affecting kidney function. Women who are pregnant or planning to become pregnant should not use this, and nursing mothers are also advised to avoid it. Special attention is needed when prescribing this medicine to children and the elderly, and elderly patients should undergo frequent renal function tests. In case of overdose, severe hypoglycemia or lactic acidosis may occur; thus, if suspected, visit a medical institution immediately for appropriate treatment. During treatment with this medicine, blood sugar, kidney function, and regular blood tests should be monitored to observe treatment effectiveness and side effects, and caution should be exercised regarding the risk of hypoglycemia while driving or operating machinery. Lastly, this medicine should be kept out of the reach of children and should not be transferred to other containers.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal bloating
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
Show 47 more
  • metallic taste
  • visual impairment
  • taste disorder
  • erythema
  • pruritus
  • urticaria
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • anemia
  • neutropenia
  • agranulocytosis
  • pancytopenia
  • peripheral neuropathy
  • vitamin B12 deficiency
  • increased liver enzymes
  • liver function impairment
  • cholestasis
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity
  • decreased serum sodium concentration
  • hypothyroidism
  • magnesium deficiency in diarrhea
  • encephalopathy
  • hair loss
  • weight gain
  • abdominal pain
  • abdominal bloating
  • palpitations
  • dizziness
  • vomiting
  • dyspepsia
  • benign prostatic hyperplasia
  • diarrhea
  • nausea
  • leg edema
  • cardiac arrest
  • rectal carcinoma
  • dizziness
  • liver dysfunction
  • arthralgia
  • facial edema
  • erectile dysfunction
  • flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly sealed container to prevent air from entering, and it is advisable to keep it at room temperature between 1 to 30 degrees Celsius. By storing it this way, the efficacy of the medicine can be well maintained.

Appearance and packaging

Appearance

White oblong film-coated tablet

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.